Know What's Happening in Venture Capital

Squawk Pod: World Autism Awareness Day - 04/03/26 | Audio Only

On World Autism Awareness Day, CNBC’s Squawk Pod featured Christopher Male, co‑founder of the Autism Impact Fund (AIF), announcing the first close of its second fund. The new vehicle expands AIF’s mandate beyond traditional behavioral‑health services to encompass broader behavioral, mental‑health and chronic‑condition markets that affect the majority of autistic individuals. Male highlighted that more than 95 % of people on the spectrum have at least one co‑occurring diagnosis, creating a trillion‑dollar addressable market. AIF’s first fund backed 17 companies and achieved two successful exits, proving that capital can generate both impact and returns. Portfolio highlights include Marobio’s blood‑test for an autism subtype, Yamo Pharmaceuticals’ therapies for core symptoms, and Imagine Pediatrics’ virtual, value‑based care platform backed by Oak, Optum Ventures and Rubicon. “Private‑sector innovation is critical because the government won’t solve this alone,” Male said, underscoring the fund’s role in accelerating diagnostics, AI‑driven precision care, and employment pathways for neurodiverse talent. He also referenced partnerships with nonprofit Jonathan’s Landing to develop integrated work‑live communities for adults with autism. The announcement signals growing investor appetite for autism‑related health tech, suggesting that future funding rounds could unlock scalable solutions, improve lifelong outcomes, and create new revenue streams for firms that can address the spectrum’s diverse needs.